AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2014
Aug 15, 2014
35124_dirs_2014-08-15_42794cd9-5cb0-4e61-8efe-261e0630de61.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2014-08-15
Reporting Person: Tardugno Michael H (CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-15 | Celsion Corporation Common Stock | P | 4000 | $3.119 | Acquired | 66521 | Direct |
Footnotes
F1: The Officer purchased the shares on the open market
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18